All In Biotech

Drug Trial Radar · NCT07849231

A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms

A Phase 1/1b Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Mutant Calreticulin Targeted Antibodies, Administered Alone or in Combination With Ruxolitinib, in Participants With CALR-mutant Myeloproliferative Neoplasms

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Jun 2030

Study completion Jun 2030

Sponsor

Lead sponsor
Damora TherapeuticsIndustry
Sponsor type
Industry
First posted
Sep 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, open-label, Phase 1/1b study designed to evaluate the safety, pharmacokinetics, immunogenicity, and preliminary efficacy of DMR-001 monotherapy in adult participants with CALR-mutated essential thrombocythemia (ET) and myelofibrosis (MF), and of DMR-001 in combination with ruxolitinib in participants with CALR-mutant MF.

Conditions

  • Myeloproliferative Neoplasms (MPNs)

Interventions

  • DMR-001Drug

    DMR-001 will be administered at protocol defined dose at a frequency of every 4 weeks.

  • RuxolitinibDrug

    Ruxolitinib will be administered according to Prescribing Information/SmPC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the safety and tolerability of DMR-001 & determine the MTD, RDE(s), and/or recommended Phase 2 dose(s) in participants with CALR-mutant MPNs, when administered as monotherapy or in combination with ruxolitinibTime frame: Up to 672 days

Locations

36 sites in 2 countries. Site status is shown where the registry gives one.

  • Site US07

    Birmingham, Alabama · Not yet recruiting

  • Site US26

    Gilbert, Arizona · Not yet recruiting

  • Site US11

    Duarte, California · Not yet recruiting

  • Site US25

    Irvine, California · Not yet recruiting

  • Site US04

    Tampa, Florida · Not yet recruiting

  • Site US15

    Atlanta, Georgia · Not yet recruiting

  • Site US21

    Kansas City, Kansas · Not yet recruiting

  • Site US18

    Baltimore, Maryland · Not yet recruiting

  • Site US03

    Boston, Massachusetts · Not yet recruiting

  • Site US12

    Boston, Massachusetts · Not yet recruiting

  • Site US06

    Ann Arbor, Michigan · Not yet recruiting

  • Site US08

    St Louis, Missouri · Not yet recruiting

  • Site US17

    Babylon, New York · Not yet recruiting

  • Site US01

    New York, New York · Not yet recruiting

  • Site US02

    New York, New York · Not yet recruiting

  • Site US14

    Charlotte, North Carolina · Not yet recruiting

  • Site US24

    Durham, North Carolina · Not yet recruiting

  • Site US13

    Winston-Salem, North Carolina · Not yet recruiting

  • Site US05

    Columbus, Ohio · Not yet recruiting

  • Site US20

    Eugene, Oregon · Not yet recruiting

  • Site US19

    Nashville, Tennessee · Not yet recruiting

  • Site US10

    Houston, Texas · Not yet recruiting

  • Site US16

    Salt Lake City, Utah · Not yet recruiting

  • Site US23

    Richmond, Virginia · Not yet recruiting

  • Site US22

    Seattle, Washington · Not yet recruiting

  • Site AU08

    Liverpool, New South Wales, Australia · Not yet recruiting

  • Site AU07

    Newcastle, New South Wales, Australia · Not yet recruiting

  • Site AU06

    Sydney, New South Wales, Australia · Not yet recruiting

  • Site AU09

    Sydney, New South Wales, Australia · Recruiting

  • Site AU11

    Brisbane, Queensland, Australia · Not yet recruiting

  • Site AU10

    Sunshine Coast, Queensland, Australia · Not yet recruiting

  • Site AU01

    Adelaide, South Australia, Australia · Not yet recruiting

  • Site AU02

    Melbourne, Victoria, Australia · Recruiting

  • Site AU03

    Melbourne, Victoria, Australia · Recruiting

  • Site AU04

    Melbourne, Victoria, Australia · Not yet recruiting

  • Site AU05

    Perth, Western Australia, Australia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.